Pluristem Joins Forces with CRISPR-IL National Consortium to Advance Development of Cutting-Edge Genome Editing Solutions for Life Science Products
Stock Information for Pluristem Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.